Authors Marija Skoblar Vidmar Onkološki inštitut Ljubljana; Univerza v Ljubljani, Medicinska fakulteta DOI: https://doi.org/10.25670/oi2023-003on Keywords: Hyper Arc, stereotactic radiosurgery, definition, brain metastases, neurocognitive function Abstract

Hyper Arc je inovativna programska in strojna oprema za izvedbo stereotaktične radiokirurgije, ki je od junija 2020 dostopna na Onkološkem inštitutu Ljubljana. Omogoča visoko natančno, monoizocentrično obsevanje v teoriji neomejenega števila možganskih tarč. Najbolj uporabna je v lokalnem zdravljenju možganskih metastaz, ki so vedno pogostejši vzrok obolevnosti in umrljivosti bolnikov z malignimi boleznimi.Glede na najnovejše raziskave in smernice se stereotaktična radiokirurgija obravnava kot primarna izbira za izboljšanje preživetja in je lahko najboljša izbira zdravljenja več metastaz v možganih. Lokalna kontrola vsake obsevane lezije in morebitna pozna toksičnost sta vedno pomembnejšega kliničnega pomena, ki lahko vplivata ne le na preživetje, temveč tudi na nevrokognitivno funkcijo in kakovost življenja.

Abstract (Eng)

Hyper Arc is an innovative software that was introduced at the Institute of Oncology Ljubljana in June 2020. It enables high-precision treatment of multiple lesions in the brain with a single isocenter – the number of targets that can be addressed with one isocenter seems to be unlimited. It is most useful in the local treatment of brain metastases, which are an increasingly frequent cause of morbidity and mortality in patients with malignant diseases. Based on the latest research and guidelines, stereotactic radiosurgery is considered the primary choice to improve survival and may be the best treatment choice for multiple brain metastases. Local control of each irradiated lesion and possible late toxicity are increasingly clinically important, which may affect not only survival but also neurocognitive function and quality of life.

How to Cite

Skoblar Vidmar, M. (2023). Hyper Arc technology for stereotactic radiosurgery treatment of brain metastases. Onkologija : A Medical-Scientific Journal, 27(1), 20–23. https://doi.org/10.25670/oi2023-003on

Issue Section

Short Scientific Article

License

Copyright (c) 2023 Marija Skoblar Vidmar

This work is licensed under a Creative Commons Attribution 4.0 International License.

The journal is published under the terms of the Creative Commons Attribution License CC-BY 4.0. The authors retain the copyright to their work without any restrictions whatsoever.

This journal is an open-access journal, meaning that all of its contents are freely accessible without any charge to the user or their institution. In accordance with the Budapest Open Access Initiative (BOAI) definition of open access, users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author, provided the authors and the journal are appropriately credited.